Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world PK/PD study of mycophenolic acid in systemic lupus erythematosus
ChiCTR2300077840Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil in systemic lupus erythematosus (SLE), sponsored by Tongji Hospital. Primary endpoint: Plasma concentration of mycophenolic acid (MPA). Started Dec 2021; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ChiCTR2300077840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077840.